Clusterin prevents aggregation of neuropeptide 106-126 in vitro

被引:34
作者
McHattie, S [1 ]
Edington, N [1 ]
机构
[1] Univ London Royal Coll Vet Surg, London NW1 0TU, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1006/bbrc.1999.0781
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prion/amyloid neuropeptide 106-126 spontaneously aggregates to form fibrillar structures in vitro. The aggregation in vitro could be prevented in a dose-related manner by clusterin, and the specificity of this action was confirmed by reversal with antibody to clusterin. The relevance of these observations is discussed in relation to previous observations that clusterin and PrPBSE colocalise in naturally occurring cases of BSE. (C) 1999 Academic Press.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 24 条
  • [1] Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
    Bruce, ME
    Will, RG
    Ironside, JW
    McConnell, I
    Drummond, D
    Suttie, A
    McCardle, L
    Chree, A
    Hope, J
    Birkett, C
    Cousens, S
    Fraser, H
    Bostock, CJ
    [J]. NATURE, 1997, 389 (6650) : 498 - 501
  • [2] ChoiMiura NH, 1996, NEUROBIOL AGING, V17, P717
  • [3] Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
    Collinge, J
    Sidle, KCL
    Meads, J
    Ironside, J
    Hill, AF
    [J]. NATURE, 1996, 383 (6602) : 685 - 690
  • [4] CASTRATION ENHANCES EXPRESSION OF GLIAL FIBRILLARY ACIDIC PROTEIN AND SULFATED GLYCOPROTEIN-2 IN THE INTACT AND LESION-ALTERED HIPPOCAMPUS OF THE ADULT MALE-RAT
    DAY, JR
    LAPING, NJ
    MCNEILL, TH
    SCHREIBER, SS
    PASINETTI, G
    FINCH, CE
    [J]. MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) : 1995 - 2002
  • [5] CHANGES IN BRAIN GENE-EXPRESSION SHARED BY SCRAPIE AND ALZHEIMER-DISEASE
    DUGUID, JR
    BOHMONT, CW
    LIU, N
    TOURTELLOTTE, WW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) : 7260 - 7264
  • [6] NEUROTOXICITY OF A PRION PROTEIN-FRAGMENT
    FORLONI, G
    ANGERETTI, N
    CHIESA, R
    MONZANI, E
    SALMONA, M
    BUGIANI, O
    TAGLIAVINI, F
    [J]. NATURE, 1993, 362 (6420) : 543 - 546
  • [7] PREDICTED ALPHA-HELICAL REGIONS OF THE PRION PROTEIN WHEN SYNTHESIZED AS PEPTIDES FORM AMYLOID
    GASSET, M
    BALDWIN, MA
    LLOYD, DH
    GABRIEL, JM
    HOLTZMAN, DM
    COHEN, F
    FLETTERICK, R
    PRUSINER, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10940 - 10944
  • [8] GOLFARB LG, 1993, P NATL ACAD SCI USA, V90, P4451
  • [9] Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2 megalin - A mechanism to prevent pathological accumulation of amyloid beta-peptide
    Hammad, SM
    Ranganathan, S
    Loukinova, E
    Twal, WO
    Argraves, WS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18644 - 18649
  • [10] Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35
    Hope, J
    Shearman, MS
    Baxter, HC
    Chong, A
    Kelly, SM
    Price, NC
    [J]. NEURODEGENERATION, 1996, 5 (01): : 1 - 11